These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25711330)

  • 1. Pulmonary function in an international sample of HIV-positive, treatment-naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Kunisaki KM; Niewoehner DE; Collins G; Nixon DE; Tedaldi E; Akolo C; Kityo C; Klinker H; La Rosa A; Connett JE;
    HIV Med; 2015 Apr; 16 Suppl 1(0 0):119-28. PubMed ID: 25711330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
    Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
    Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.
    Costiniuk CT; Nitulescu R; Saneei Z; Wasef N; Salahuddin S; Wasef D; Young J; de Castro C; Routy JP; Lebouché B; Cox J; Smith BM; Ambroise S; Pexos C; Patel M; Szabo J; Haraoui LP; de Pokomandy A; Tsoukas C; Falutz J; LeBlanc R; Giannakis A; Frenette C; Jenabian MA; Bourbeau J; Klein MB
    HIV Med; 2019 Mar; 20(3):192-201. PubMed ID: 30620136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin.
    Thudium RF; Lundgren J; Benfield T; Nordestgaard BG; Borges ÁH; Gerstoft J; Nielsen SD; Ronit A;
    HIV Med; 2018 Nov; 19(10):745-750. PubMed ID: 30160349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Obstructive Pulmonary Disease Prevalence and Associated Factors in a Setting of Well-Controlled HIV, A Cross-Sectional Study.
    Kayongo A; Wosu AC; Naz T; Nassali F; Kalyesubula R; Kirenga B; Wise RA; Siddharthan T; Checkley W
    COPD; 2020 Jun; 17(3):297-305. PubMed ID: 32462945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy.
    MacDonald DM; Melzer AC; Collins G; Avihingsanon A; Crothers K; Ingraham NE; Mugerwa H; Ristola M; Shuter J; Kunisaki KM;
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):e85-e92. PubMed ID: 29985804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Sharma S; Babiker AG; Emery S; Gordin FM; Lundgren JD; Neaton JN; Bakowska E; Schechter M; Wiselka MJ; Wolff MJ;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):30-6. PubMed ID: 25711321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study.
    North CM; Allen JG; Okello S; Sentongo R; Kakuhikire B; Ryan ET; Tsai AC; Christiani DC; Siedner MJ
    Lung; 2018 Feb; 196(1):49-57. PubMed ID: 29260309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Achhra AC; Mocroft A; Ross MJ; Ryom L; Lucas GM; Furrer H; Neuhaus J; Somboonwit C; Kelly M; Gatell JM; Wyatt CM;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):55-63. PubMed ID: 25711324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between baseline biomarkers and lung function in HIV-positive individuals.
    MacDonald DM; Zanotto AD; Collins G; Baker JV; Czarnecki M; Loiza E; Nixon DE; Papastamopoulos V; Wendt CH; Wood R; Kunisaki KM;
    AIDS; 2019 Mar; 33(4):655-664. PubMed ID: 30601153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV is associated with airway obstruction: a matched controlled study.
    Makinson A; Hayot M; Eymard-Duvernay S; Ribet C; Raffi F; Pialoux G; Zucman D; Poizot-Martin I; Bonnet F; Abgrall S; Tattevin P; Cheret A; Ferry T; Mauboussin JM; Marchand L; Rouzaud C; Reynes J; Zins M; Le Moing V;
    AIDS; 2018 Jan; 32(2):227-232. PubMed ID: 29135582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of electronic health record data for the diagnosis of chronic obstructive pulmonary disease in persons living with HIV and uninfected persons.
    Crothers K; Rodriguez CV; Nance RM; Akgun K; Shahrir S; Kim J; W Soo Hoo G; Sharafkhaneh A; Crane HM; Justice AC
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):140-147. PubMed ID: 29923258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic obstructive pulmonary disease in patients diagnosed with HIV without prior antiretroviral treatment.
    Romero-López Z; Rojas-Cisneros FA; Ochoa-Vázquez MD; Rico-Méndez FG; Mata-Marín JA
    Gac Med Mex; 2020; 156(4):286-293. PubMed ID: 32831338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country.
    Ddungu A; Semitala FC; Castelnuovo B; Sekaggya-Wiltshire C; Worodria W; Kirenga BJ
    PLoS One; 2021; 16(8):e0256121. PubMed ID: 34388209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era?
    Madeddu G; Fois AG; Calia GM; Babudieri S; Soddu V; Becciu F; Fiori ML; Spada V; Lovigu C; Mannazzu M; Caddeo A; Piras B; Pirina P; Mura MS
    Infection; 2013 Apr; 41(2):347-53. PubMed ID: 22971938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Wright EJ; Grund B; Cysique LA; Robertson KR; Brew BJ; Collins G; Shlay JC; Winston A; Read TR; Price RW;
    HIV Med; 2015 Apr; 16 Suppl 1():97-108. PubMed ID: 25711328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of Early COPD in Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study.
    Çolak Y; Afzal S; Nordestgaard BG; Lange P; Vestbo J
    Am J Respir Crit Care Med; 2021 May; 203(10):1245-1256. PubMed ID: 33142077
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors associated with pulmonary impairment in HIV-infected South African adults.
    Gupte AN; Wong ML; Msandiwa R; Barnes GL; Golub J; Chaisson RE; Hoffmann CJ; Martinson NA
    PLoS One; 2017; 12(9):e0184530. PubMed ID: 28902919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional analysis of diagnosis and management of chronic obstructive pulmonary disease in people living with HIV: Opportunities for improvement.
    Zifodya JS; Triplette M; Shahrir S; Attia EF; Akgun KM; Soo Hoo GW; Rodriguez-Barradas MC; Wongtrakool C; Huang L; Crothers K
    Medicine (Baltimore); 2021 Sep; 100(37):e27124. PubMed ID: 34664836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.